SCHEMBL2760705

SCHEMBL2760705

NC(=O)Oc1ccc([CH]CCO)cn1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NNMT P40261 2/20 0.36
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
MKNK1 Q9BUB5 1/20 0.33
MKNK2 Q9HBH9 1/20 0.33
HSD17B10 Q99714 1/20 0.32
MAPT P10636 1/20 0.32
POLB P06746 2/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
OPRM1 P35372 1/20 0.30
OPRD1 P41143 1/20 0.30
OPRK1 P41145 1/20 0.30
GAA P10253 1/20 0.30
SIRT6 Q8N6T7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14480241 0.89 NNMT (0.37) NNMTALDH1A1KDM4EL3MBTL1MKNK1
SCHEMBL17477194 0.85 ALDH1A1 (0.49) NNMTALDH1A1KDM4EL3MBTL1MKNK1
SCHEMBL28849760 0.80 PARP1 (0.40) NNMTALDH1A1KDM4EL3MBTL1MKNK1
SCHEMBL23501674 0.79 ALDH1A1 (0.44) NNMTALDH1A1KDM4EL3MBTL1MKNK1
SCHEMBL28559496 0.79 NNMT (0.40) NNMTALDH1A1KDM4EL3MBTL1MKNK1
SCHEMBL28559493 0.79 NNMT (0.40) NNMTALDH1A1KDM4EL3MBTL1MKNK1
SCHEMBL2760651 0.77 KMT2A (0.45) KMT2AOPRM1OPRD1OPRK1SIRT6
SCHEMBL3733475 0.77 KIF11 (0.43) ALDH1A1L3MBTL1POLBKMT2A
SCHEMBL15775597 0.76 NNMT (0.35) NNMTALDH1A1KDM4EL3MBTL1MKNK1
SCHEMBL14785651 0.76 KMT2A (0.43) ALDH1A1KDM4EMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150266822-A1 Amide Compounds, Compositions And Uses Thereof RENOVIS, INC. 2015-09-24 US claimed
US-20150266822-A1 Amide Compounds, Compositions And Uses Thereof RENOVIS, INC. 2015-09-24 US disclosed
US-8946439-B2 Amide compounds, compositions and uses thereof EVOTEC AG (DE) 2015-02-03 US disclosed
EP-2262766-A2 AMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF Renovis, Inc. (US) 2010-12-22 EP disclosed
WO-2009110985-A2 AMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF RENOVIS, INC. (US) 2009-09-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150266822-A1 Amide Compounds, Compositions And Uses Thereof IL1B, ADORA2B, AVPR1B NNMT 2205/4885ALDH1A1 1016/4885KDM4E 3792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.